BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 20086232)

  • 21. PARC report: health outcomes and value of personalized medicine interventions: impact on patient care.
    Mitropoulou C; Litinski V; Kabakchiev B; Rogers S; P Patrinos G
    Pharmacogenomics; 2020 Jul; 21(11):797-807. PubMed ID: 32635813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Genomics from bench to bedside: a change in perspective].
    Bourgain C
    Med Sci (Paris); 2014 Nov; 30 Spec No 2():14-7. PubMed ID: 25407452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Payer view of personalized medicine.
    Pezalla EJ
    Am J Health Syst Pharm; 2016 Dec; 73(23):2007-2012. PubMed ID: 27864208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barriers to integrating personalized medicine into clinical practice: a best-worst scaling choice experiment.
    Najafzadeh M; Lynd LD; Davis JC; Bryan S; Anis A; Marra M; Marra CA
    Genet Med; 2012 May; 14(5):520-6. PubMed ID: 22241089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden.
    Verhoef TI; Redekop WK; Langenskiold S; Kamali F; Wadelius M; Burnside G; Maitland-van der Zee AH; Hughes DA; Pirmohamed M
    Pharmacogenomics J; 2016 Oct; 16(5):478-84. PubMed ID: 27272045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Precision Medicine: From Science To Value.
    Ginsburg GS; Phillips KA
    Health Aff (Millwood); 2018 May; 37(5):694-701. PubMed ID: 29733705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Essential elements of personalized medicine.
    Burke W; Brown Trinidad S; Press NA
    Urol Oncol; 2014 Feb; 32(2):193-7. PubMed ID: 24321254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Progress in precision medicine: a scientific perspective].
    Wang B; Li LM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan; 38(1):1-2. PubMed ID: 28100368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Technology: Read the instructions.
    Scott AR
    Nature; 2016 Sep; 537(7619):S54-6. PubMed ID: 27602740
    [No Abstract]   [Full Text] [Related]  

  • 31. Opportunities and Challenges in Cardiovascular Pharmacogenomics: From Discovery to Implementation.
    Roden DM; Van Driest SL; Wells QS; Mosley JD; Denny JC; Peterson JF
    Circ Res; 2018 Apr; 122(9):1176-1190. PubMed ID: 29700066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "
    Gemmati D; Varani K; Bramanti B; Piva R; Bonaccorsi G; Trentini A; Manfrinato MC; Tisato V; Carè A; Bellini T
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Precision Medicine, Cardiovascular Disease and Hunting Elephants.
    Joyner MJ
    Prog Cardiovasc Dis; 2016; 58(6):651-60. PubMed ID: 26902518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
    Weitzel JN; Blazer KR; MacDonald DJ; Culver JO; Offit K
    CA Cancer J Clin; 2011; 61(5):327-59. PubMed ID: 21858794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies.
    Trosman JR; Weldon CB; Douglas MP; Deverka PA; Watkins JB; Phillips KA
    Value Health; 2017 Jan; 20(1):40-46. PubMed ID: 28212967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of pharmacogenetics-guided warfarin therapy vs. alternative anticoagulation in atrial fibrillation.
    Pink J; Pirmohamed M; Lane S; Hughes DA
    Clin Pharmacol Ther; 2014 Feb; 95(2):199-207. PubMed ID: 24067746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Innovations in Genomics and Big Data Analytics for Personalized Medicine and Health Care: A Review.
    Hassan M; Awan FM; Naz A; deAndrés-Galiana EJ; Alvarez O; Cernea A; Fernández-Brillet L; Fernández-Martínez JL; Kloczkowski A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How to Invest in Getting Cost-effective Technologies into Practice? A Framework for Value of Implementation Analysis Applied to Novel Oral Anticoagulants.
    Faria R; Walker S; Whyte S; Dixon S; Palmer S; Sculpher M
    Med Decis Making; 2017 Feb; 37(2):148-161. PubMed ID: 27105651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of pharmacogenetics in public health and clinical health care: a SWOT analysis.
    Kapoor R; Tan-Koi WC; Teo YY
    Eur J Hum Genet; 2016 Dec; 24(12):1651-1657. PubMed ID: 27577547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The next chapter for African genomics.
    Maxmen A
    Nature; 2020 Feb; 578(7795):350-354. PubMed ID: 32076222
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.